Cover Image

Editorial: The developments of metal-based agents against lung cancer

Saved in:

Bibliographic Details
Main Authors:	Yi Gou (Author), Li Liu (Author), Hong Liang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advances in thiosemicarbazone metal complexes as anti-lung cancer agents
by: Xian-Guang Bai, et al.
Published: (2022)

Natural Products-Based Metallic Nanoparticles as Antimicrobial Agents
by: Deny Susanti, et al.
Published: (2022)

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
by: Fanfan Zhou, et al.
Published: (2022)

Novel compounds in the treatment of lung cancer: current and developing therapeutic agents
by: Rudi Bao, et al.
Published: (2011)

Metal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents
by: Tatyana I. Shabatina, et al.
Published: (2023)

1,2,3-Triazole-Containing Compounds as Anti-Lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure-Activity Relationship
by: Ting Liang, et al.
Published: (2021)

Agents to treat BRAF-mutant lung cancer
by: Jean G Bustamante Alvarez, et al.
Published: (2019)

Current status of iridium-based complexes against lung cancer
by: Tongfu Yang, et al.
Published: (2022)

Fenton metal nanomedicines for imaging-guided combinatorial chemodynamic therapy against cancer
by: Peng Liu, et al.
Published: (2022)

Editorial: Nature Inspired Protective Agents Against Oxidative Stress
by: Manuela Oliverio, et al.
Published: (2022)

Heavy Metal-Based Nanoparticles as High-Performance X-ray Computed Tomography Contrast Agents
by: Mohammad Yaseen Ahmad, et al.
Published: (2023)

Metal-Based Nanoparticles for Cancer Metalloimmunotherapy
by: Ivan Hardianto Suliman, et al.
Published: (2023)

Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer
by: Priya Mondal, et al.
Published: (2023)

Lactone Stabilized by Crosslinked Cyclodextrin Metal-Organic Frameworks to Improve Local Bioavailability of Topotecan in Lung Cancer
by: Ting Xiong, et al.
Published: (2022)

Editorial: Novel small molecules in targeted cancer therapy
by: Rong Li, et al.
Published: (2023)

Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer
by: Deepal Vora, et al.
Published: (2022)

Development of a traditional Chinese medicine‐based agent for the treatment of cancer cachexia
by: Kun‐Chang Wu, et al.
Published: (2022)

Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma
by: Yi Luo, et al.
Published: (2020)

Development of 10-Hydroxycamptothecin-crizotinib conjugate based on the synergistic effect on lung cancer cells
by: Zhen Liu, et al.
Published: (2023)

Editorial: Targeted Subcellular Delivery of Anti-cancer Agents
by: David A. Jans, et al.
Published: (2019)

Lipid-Based Inhalable Micro- and Nanocarriers of Active Agents for Treating Non-Small-Cell Lung Cancer
by: Sona Gandhi, et al.
Published: (2023)

Characteristics of Metallic Nanoparticles (Especially Silver Nanoparticles) as Anti-Biofilm Agents
by: Hongze Li, et al.
Published: (2024)

Editorial: Molecular pharmacological approaches against lung diseases: targeted drug discovery
by: Poonam Arora, et al.
Published: (2024)

Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents
by: Yan Wang, et al.
Published: (2023)

A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK
by: Ma Y, et al.
Published: (2024)

miR-206/133b Cluster: A Weapon against Lung Cancer?
by: Jing-Yu Pan, et al.
Published: (2017)

Development of mobile health-based self‐management support for patients with lung cancer: A stepwise approach
by: Xiaosha Ni, et al.
Published: (2022)

Metal complexes of saccharin and thiosaccharin as potential anticancer and antimicrobial agents
by: Ceyda Icsel, et al.
Published: (2024)

Lycopene Protects against Smoking-Induced Lung Cancer by Inducing Base Excision Repair
by: Junrui Cheng, et al.
Published: (2020)

Metal-Based G-Quadruplex Binders for Cancer Theranostics
by: Elisa Palma, et al.
Published: (2021)

The role of metal ions in the occurrence, progression, drug resistance, and biological characteristics of gastric cancer
by: Pengtuo Xiao, et al.
Published: (2024)

Editorial: Model-Based Evaluation of Antimicrobial Agents in Children
by: Wei Zhao, et al.
Published: (2021)

Editorial: Application of lung ultrasound in the management of pediatric lung diseases
by: Jing Liu, et al.
Published: (2023)

Editorial: The Association Between Greenness, Health, and Well-Being in Urban Environments
by: Zhonghua Gou, et al.
Published: (2021)

Folic Acid-Functionalized Metal-Organic Framework Nanoparticles as Drug Carriers Improved Bufalin Antitumor Activity Against Breast Cancer
by: Hairong Zeng, et al.
Published: (2022)

Recent Developments in Heteroatom/Metal-Doped Carbon Dot-Based Image-Guided Photodynamic Therapy for Cancer
by: Rajkumar Sekar, et al.
Published: (2022)

Low-density lipoprotein encapsulated thiosemicarbazone metal complexes is active targeting vehicle for breast, lung, and prostate cancers
by: Laila Jaragh-Alhadad, et al.
Published: (2022)

Development of Novel Paclitaxel-Loaded ZIF-8 Metal-Organic Framework Nanoparticles Modified with Peptide Dimers and an Evaluation of Its Inhibitory Effect against Prostate Cancer Cells
by: Heming Zhao, et al.
Published: (2023)

Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease
by: Xiao Li, et al.
Published: (2023)

Retentiveness of implant-supported metal copings using different luting agents
by: Farahnaz Nejatidanesh, et al.
Published: (2012)